Karen Drexler - 16 Nov 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
Director
Signature
Karen Drexler, director
Issuer symbol
RMD
Transactions as of
16 Nov 2023
Transactions value $
$383,418
Form type
4
Filing time
20 Nov 2023, 16:47:31 UTC
Previous filing
16 Jun 2023
Next filing
30 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $0 +884 +11.1% $0.000000 8,871 16 Nov 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Award $383,418 +2,575 $148.90 2,575 16 Nov 2023 ResMed Common Stock 2,575 $148.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2024, or the annual shareholder's meeting in the year following the grant date.
F2 Represents the date options become exercisable. Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date.